{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:11:39Z","timestamp":1790629899388,"version":"4.1.0"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["D43TW010132"],"award-info":[{"award-number":["D43TW010132"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      In low-resource settings, magnesium sulphate (MgSO\n                      <jats:sub>4)<\/jats:sub>\n                      for preeclampsia is administered majorly through an injection into the gluteal muscles 4-hourly for 24 hours. The repeated injections are very painful and may lead to infection, abscess formation, and reduced compliance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the acceptability of Springfusor\u00ae pump for the administration of Magnesium Sulphate in preeclampsia and eclampsia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Randomized Open Label Clinical Trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The study was conducted at Kawempe National Referral Hospital. Eligible women had a systolic blood pressure of \u2265\n                      <jats:underline>1<\/jats:underline>\n                      40mmHg and or diastolic blood pressure &gt;90mmHg, proteinuria \u2265+1, and the physician\u2019s decision to start on MgSO\n                      <jats:sub>4<\/jats:sub>\n                      . Four-hundred-ninety-six participants were randomized to a Springfusor\u00ae pump group (n = 248) or control (standard of care) (n = 248) administration of MgSO\n                      <jats:sub>4<\/jats:sub>\n                      . Intervention group had a loading dose (4gm of 50% MgSO\n                      <jats:sub>4<\/jats:sub>\n                      intravenously over 20 minutes) and maintenance therapy (1gm of 50% MgSO\n                      <jats:sub>4<\/jats:sub>\n                      intravenously per hour for 24 hours) administered using the Springfusor\u00ae. The standard of care (SOC) group received a loading dose of 4gm of 20% MgSO\n                      <jats:sub>4<\/jats:sub>\n                      IV over 15\u201320 minutes, followed by 10gm of 50% MgSO\n                      <jats:sub>4<\/jats:sub>\n                      intramuscular (5gm in each buttock) and a maintenance dose of 5gm of 50% MgSO\n                      <jats:sub>4<\/jats:sub>\n                      was administered IM every 4 hours for 24 hours. Both arms received the rest of the care for preeclampsia\/eclampsia as per the hospital guidelines. Acceptability of the method of administration was assessed using a Likert scale (1\u20135; 1 and 2: acceptable and 3\u20135: unacceptable). Pain at the site of MgSO\n                      <jats:sub>4<\/jats:sub>\n                      administration was assessed using a Visual Analogue Scale 1\u20137, (1 minimal pain and 7 worst pain). Comparisons were assessed with the Chi-square test, Mann Whitney-Wilcoxon test, and Students\u2019 t-test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Intervention arm; was more acceptable than the standard of care arm, (95.3% vs70.3%; p&lt;0.001), had a lower median pain score, (2(CI: 2\u20132), vs 4(CI: 4\u20135) p&lt;0.001), and fewer side effects. Maternal mortality was comparable between groups (0.8% in the intervention arm vs 1.2% in the IM arm).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec006\">\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Trial No\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/pactr.samrc.ac.za\" xlink:type=\"simple\">PACTR201712002887266<\/jats:ext-link>\n                      (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/pactr.samrc.ac.za\/\" xlink:type=\"simple\">https:\/\/pactr.samrc.ac.za\/<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0286361","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T13:37:06Z","timestamp":1718199426000},"page":"e0286361","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Randomized trial to compare acceptability of magnesium sulphate administration for preeclampsia and eclampsia: Springfusor pump versus standard of care"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7561-0167","authenticated-orcid":true,"given":"Sam","family":"Ononge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annettee","family":"Nakimuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josaphat","family":"Byamugisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Adroma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kiondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Easterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillary","family":"Bracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"issue":"1","key":"pone.0286361.ref001","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mob.2000.107928","article-title":"Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy","volume":"183","year":"2000","journal-title":"American journal of obstetrics and gynecology"},{"issue":"3","key":"pone.0286361.ref002","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia.","volume":"33","author":"L. Duley","year":"2009","journal-title":"Seminars in perinatology"},{"issue":"1","key":"pone.0286361.ref003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12884-023-05420-z","article-title":"Prediction of pre-eclampsia at St. Mary\u2019s hospital lacor, a low-resource setting in northern Uganda, a prospective cohort study.","volume":"23","author":"S Awor","year":"2023","journal-title":"BMC Pregnancy and Childbirth"},{"issue":"11","key":"pone.0286361.ref004","first-page":"e31013","article-title":"Maternal and Fetal Outcomes of Preeclampsia With and Without Severe Features in King Abdulaziz University Hospital, Jeddah, Saudi Arabia: A Retrospective Study.","volume":"14","author":"A Mousa","year":"2022","journal-title":"Cureus."},{"issue":"6","key":"pone.0286361.ref005","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"L Say","year":"2014","journal-title":"The Lancet Global health"},{"key":"pone.0286361.ref006","unstructured":"WHO Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. WHO Guidelines Approved by the Guidelines Review Committee. Geneva2011."},{"issue":"6","key":"pone.0286361.ref007","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0002-9378(78)90816-5","article-title":"Problems encountered in the treatment of pregnancy-induced hypertension. A point of view","volume":"131","author":"FP Zuspan","year":"1978","journal-title":"American journal of obstetrics and gynecology"},{"issue":"2","key":"pone.0286361.ref008","first-page":"131","article-title":"The use of the magnesium ion in the management of eclamptogenic toxemias","volume":"100","author":"JA Pritchard","year":"1955","journal-title":"Surgery, gynecology & obstetrics."},{"issue":"1","key":"pone.0286361.ref009","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/0974150X211057961","article-title":"Pain, Drug Leakage and Inflammation Associated with Intramuscular Injections of Magnesium Sulfate in Preeclamptic Women: A Descriptive Study.","volume":"18","author":"JJ Babu","year":"2022","journal-title":"Nursing & Midwifery Research Journal"},{"issue":"3","key":"pone.0286361.ref010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/1471-0528.16913","article-title":"Factors affecting use of magnesium sulphate for pre-eclampsia or eclampsia: a qualitative evidence synthesis.","volume":"129","author":"KE Eddy","year":"2022","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"pone.0286361.ref011","first-page":"2017","volume":"25","author":"Go Medicals Industries Pty Ltd","journal-title":"Innovative Products to improve common medical procedures"},{"issue":"1","key":"pone.0286361.ref012","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12884-018-1919-6","article-title":"A randomized trial comparing the pharmacology of magnesium sulfate when used to treat severe preeclampsia with serial intravenous boluses versus a continuous intravenous infusion","volume":"18","author":"T Easterling","year":"2018","journal-title":"BMC pregnancy and childbirth"},{"issue":"1","key":"pone.0286361.ref013","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.preghy.2011.09.002","article-title":"Treatment approaches for preeclampsia in low-resource settings: A randomized trial of the Springfusor pump for delivery of magnesium sulfate.","volume":"2","author":"S Mundle","year":"2012","journal-title":"Pregnancy hypertension"},{"issue":"5","key":"pone.0286361.ref014","first-page":"580","article-title":"A double-blind comparison of vecuronium administered by the Springfusor infusion device to vecuronium by intermittent bolus injection in critically ill adult patients.","volume":"22","author":"R Freebairn","year":"1994","journal-title":"Anaesthesia and"},{"issue":"5","key":"pone.0286361.ref015","first-page":"132","article-title":"Consort 2010 statement on randomised controlled trials.","volume":"103","author":"JF Murphy","year":"2010","journal-title":"Ir Med J"},{"issue":"12","key":"pone.0286361.ref016","article-title":"Magnesium sulphate versus diazepam for eclampsia.","author":"L Duley","year":"2010","journal-title":"The Cochrane database of systematic reviews."},{"key":"pone.0286361.ref017","first-page":"68","article-title":"Fear of injections in young adults: prevalence and associations","volume":"3","author":"Y Nir","year":"2003","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"2","key":"pone.0286361.ref018","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/08897077.2012.763083","article-title":"Aversion to injection limits acceptability of extended-release naltrexone among homeless, alcohol-dependent patients.","volume":"34","author":"PD Friedmann","year":"2013","journal-title":"Subst Abus."},{"key":"pone.0286361.ref019","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2147\/PPA.S187120","article-title":"Mode of injection and treatment adherence: results of a survey characterizing the perspectives of health care providers and US women 18\u201345 years old.","volume":"13","author":"DL Gandell","year":"2019","journal-title":"Patient Prefer Adherence"},{"key":"pone.0286361.ref020","first-page":"923","article-title":"The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection.","volume":"9","author":"JF Jin","year":"2015","journal-title":"Patient Prefer Adherence"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0286361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T13:37:28Z","timestamp":1718199448000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0286361"}},"subtitle":[],"editor":[{"given":"Ahmed Mohamed","family":"Maged","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0286361","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.05.16.23290038","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]}}}